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Abstract
Background—Disease patterns in Mexican-American health-disparity populations differ from 
larger United States populations.
Aims—Determine frequency of gastrointestinal cancers in Mexican Americans.
Methods—We analyzed self-reported data from the Cameron County Hispanic Cohort where we 
find high rates of risk factors for cancer: obesity (48.5%), diabetes (30.7%). Participants provided 
cancer histories about themselves and first and second degree relatives. Logistic regression models 
assessed risk factors. Frequencies of cancer sites were ranked and validated using concurrent age 
local cancer registry data.
Results—Among 9,249 individuals (participants and their relatives) there were 1,184 individuals 
with reports of cancer. Among cohort participants under 70 years of age the most significant risk 
factor for all-cause cancers was diabetes (OR 3.57, 95% CI 1.32, 9.62). Participants with 
metabolic syndrome were significantly more likely to report cancer in relatives (1.73 (95%CI 1.26, 
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2.37). Among cancers in fathers, liver cancer was ranked third, stomach fourth, colorectal sixth 
and pancreas tenth. In mothers, stomach was third, liver fourth, colorectal seventh and pancreas 
eleventh. The unusual prominence of these cancers in Mexican Americans, including liver cancer, 
was supported by age-adjusted incidence in local registry data.
Conclusions—Gastrointestinal system cancers, particularly liver cancer, in a Mexican American 
health disparity cohort and their relatives rank higher than in other ethnicities and are associated 
with high rates of diabetes and metabolic syndrome. Effective prevention of diabetes and low-tech, 
high-quality screening strategies for gastrointestinal cancers are needed in health disparity 
communities.
Keywords
gastrointestinal cancer; liver; diabetes; Mexican Americans
Background & Aims
Cancer is a major contributor to the pandemic of non-communicable diseases (NCDs) 
together with cardiovascular diseases, chronic lung disease and diabetes.(1) The World 
Health Organization (WHO) in 2014 estimated the global burden of new cancer cases will 
rise from the current 14 million annually to 22 million by the 2040s, when it will likely 
account for 13 million deaths each year.(2) Obesity and diabetes have been recently linked to 
increased cancer incidence and mortality, particularly cancers of the gastrointestinal system 
and breast.(3,4) Though much emphasis has been placed on cancers of the lung, breast and 
prostate, the increase in gastrointestinal cancers may have been under-appreciated.
In the United States (U.S.) the Hispanic population is estimated to account for 30% of the 
population by the year 2020.(5) However, sub-populations vary and their origin is not 
always distinguished.(6,7) The largest sub-group (64%) is Mexican-American, among whom 
diabetes-related chronic diseases are prominent and where severe socioeconomic and health 
disparities are similar to those found globally in low-and middle-income countries (LMICs) 
with high NCD prevalence.(6,8-11) Cancer (21.1%) has now surpassed heart disease 
(20.9%) as a leading cause of death among Hispanics.(12) However, estimates suffer from 
underreporting.(13-16) The unique socioeconomic, age distribution and immigration 
histories of Hispanics together with high rates of poverty and lack of insurance may account 
for much of these differences.(12)
Hispanics are more likely to present with advanced cancers and have lower five-year 
survival rates.(13) Mexican-Americans also experience lower screening rates for essentially 
preventable or treatable cancers than any other ethnic group.(6,13)
These disparities are more pronounced along the US/Mexico border than in any other region 
of the U.S. such that accurate data on cancer-specific rates are difficult to ascertain.(17) 
Age-adjusted rates of diabetes are higher in Hispanics than in non-Hispanics in the U.S., 
with Mexican-Americans having among the highest incidence and mortality rates.(18-21) 
Along the U.S./Mexico border Mexican Americans have 30.7% prevalence of diabetes and 
49.5% for obesity.(22) In this environment as in LMICs there is little reliable mortality data 
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and weak surveillance systems.(1) Data from cancer registries, however, do suggest elevated 
incidence of liver cancers in this population.(23) On the U.S./Mexico border the majority of 
reports are from hospitals but since two thirds of the population has no health insurance 
many cases are not recorded and cancer registry data are limited. Such patients often seek 
terminal care elsewhere, frequently in adjacent Mexico.(11,24) Our objective was to 
estimate the burden and frequency of cancers in an extensively documented Mexican 
American community cohort living in socioeconomic conditions similar to many LMICs to 
provide insight into the impact of gastrointestinal cancers nationally and globally.(11,25)
Methods
Study Design
We analyzed cross-sectional community-based data from participants in our Cameron 
County Hispanic Cohort (CCHC). For the purposes of this study, the main outcome 
measures were self-reported cancers in participants and their first and second degree 
relatives. The CCHC now numbers over 3,000 individuals recruited from their households in 
Brownsville on the US/Mexico border in one of the two poorest counties in the United 
States.(10) Recruiting began in 2004 and is ongoing with 5 and 10 year follow-up in hand. 
This cohort has provided extensive data showing weighted prevalence of a range of diseases 
in this health disparity community. Questionnaires are administered in English or Spanish, 
with about 70% of the participants electing Spanish.
IRB Approval
All protocols, procedures and consent forms were reviewed and approved by The University 
of Texas Health Science Center, Committee for the Protection of Human Subjects (HSC-
SPH-03-007-B).
Setting and Data Collection
CCHC participants aged 18 years and older are recruited using two-stage randomized 
sampling of households in the city of Brownsville, Texas.(25) After obtaining written 
informed consent, extensive socio-demographic and medical histories including cancers are 
collected in our Clinical Research Unit in the language of choice of the participants. Each 
participant is also asked about history of cancers in first (parents and siblings) and second 
(grandparents and parents' siblings) degree relatives. We measured diabetes status (fasting 
blood glucose and glycosylated hemoglobin), height, weight, lipid profile and fasting 
insulin. Body Mass Index (BMI) was calculated from kg/m2 and insulin resistance using the 
homeostasis model assessment equation (HOMA-IR).(26) For first and second degree 
relatives we used participant-reported data, which we call “participant-reported” for 
simplicity. For parents of participants, data were limited to diabetes status and country of 
birth. For other relatives no data other than occurrence of cancer were collected.
Statistical analysis
All data were analyzed using SAS software version 9.2 TS level 1MO (SAS Institute Inc., 
Cary, NC). All hypotheses were tested at the 0.05 level of significance.
Garza et al. Page 3














We used sampling weights as previously described.(25) Descriptive statistics examined 
sociodemographic and biological risk factors using a design-based analysis incorporating 
age- and gender-adjusted sampling weights, stratification by socioeconomic status and 
allowing for clustering by census block and household. Weighted odds ratios and their 95% 
confidence intervals are presented. We took all variables in the univariable analysis with p 
values less than 0.25 and assessed their significance in a multivariable weighted logistic 
regression model controlling for age and gender.
First and second degree relatives
We assessed the proportion of all cancer events among parents by major cancer sites and by 
gender, and association with the parent's diabetes status and country of birth. Data from 
parents were then ranked by individual cancer relative frequencies.
Comparison with registry data
To validate our observations we compared our findings to public and published data 
available for Hispanics and non-Hispanics across the nation, for Hispanics in Texas and data 
from Mexico.(27-30) Finally we reviewed cancer site incidence by ethnic origin using Texas 
Cancer Registry Data.(28) (Texas cancer data provided by the Texas Cancer Registry, 
Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, 
211 E. 7th Street, Suite 325, Austin, TX 78701).
Results
Overall reports of cancer events
The figure shows that there were 1,184 records of cancer from 9,249 reports on individuals 
(alive or dead) given us by cohort participants (12.8%); 2,547 participants, 6,702 first and 
second degree relatives (2,314 fathers, 2,513 mothers and 1,875 other close relatives). 
Seventy one personal cancer histories at the time of questioning were elicited from the 
participants (2.8%). In first degree relatives there were 305 reports of all cause cancers in 
fathers (13.2%), 318 in mothers (12.7%) and 288 in siblings. In second degree relatives there 
were 202 reports of all cause cancers.
Participants
Socio-demographic and health characteristics of the 2,547participants and their family 
histories of cancer are shown in table 1. More than half of all participants were born in 
Mexico, the majority living below the poverty level, with high unemployment. In a previous 
analysis we found that more than two thirds of cohort participants were uninsured.(22) The 
weighted prevalence of all cause cancer was 4.2%. Diabetes was a highly significant risk 
factor (OR 2.62, 95%CI 1.19, 5.79). Not surprisingly, older age and smoking were also risk 
factors. Because of the limited sample size and timescale of the cohort itself for cancer 
endpoints, numbers of reported cancers for individual sites in participants were too small for 
separate analyses.
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Table 2 shows the relationship of characteristics of the participants to family histories of 
cancer in relatives. Participants who met the definition for metabolic syndrome had an odds 
ratio of 1.73 (95%CI 1.26, 2.37) of having had at least one parent with cancer, and an odds 
ratio of 3.40(95%CI 1.06, 10.91) if two or more siblings also had cancer.
In order to determine independent, significant variables we built a weighted multivariable 
logistic regression model including variables we found to have a significant association with 
cancer together with gender, cancer in parent, smoking status and country of birth. We 
constructed two-way statistical interactions to examine for possible effect modifications in 
the model and found that the interaction between age and diabetes status was statistically 
significant (p=0.0078). After including the interaction effect in the model the adjusted odds 
ratio for cancer in diabetes versus no diabetes was 22.98, (95%CI 2.84, 185.76) with change 
of 0.96 (95% CI 0.93, 0.99) for each year increase in age. Finally we determined that the 
effect of age on the diabetes risk was bimodal; those under the age of 70 with diabetes were 
more likely to report cancer (OR 3.57, 95% CI 1.32, 9.62) and those over 70 less likely if 
they had diabetes (OR 0.64 95% CI 0.16, 2.58). We were unable to determine independently 
whether diabetes was significantly associated with any single cancer site due to small 
numbers (data not shown).
Family history of cancer among first degree relatives (parents)
A higher percentage of the parents compared to participants were born in Mexico (80.8% of 
mothers and 77.2% of fathers). Among parents participant-reported diabetes was also high 
(34.4% in mothers and 24.9% in fathers). Diabetes was reported for 13.9% of mothers and 
12.7% of fathers. Diabetes status was missing for 104 mothers and 304 fathers as was cancer 
status of 61 mothers and 248 fathers. Table 3 lists in order of frequency the most commonly 
reported cancers among parents and association with diabetes in the parent. Being born in 
the U.S. was significant for all cancers (overall Odds Ratio of 1.38, 95% CI 1.12,1.70, for 
both genders). Regardless of gender and excluding gender-specific cancer sites, lung cancer 
was by far the most frequent with 100 reports (2.1%). The next three most frequently 
reported (excluding gender-specific sites) were all cancers of the gastrointestinal system: 
stomach (46; 0.95%), liver (36; 0.74%) and colon/rectum (24; 0.43%). Gender-specific 
cancer sites were also frequently reported with cervix/uterus leading with 66 reports in 
mothers (2.6%) followed by breast (2.4%) and ovarian (1.4%) cancers. In fathers prostate 
cancer was second most common cancer (2.6%) after lung cancer (3.1%).
Comparison with different populations
Table 4 compares ranked cancer frequency for the parents with cancer registry data from 
other populations in the U.S. and Mexico. In most of these populations the two most 
frequent cancers in women are cervix/uterus and breast. However, liver and stomach cancers 
were ranked higher in the mothers of our participants than in any other U.S. population. 
These rankings resembled more closely those from Mexico. Similar analysis for fathers 
shows that the two leading reported cancer sites, lung and prostate cancer, are also among 
the top three leading cancer sites for Hispanic men in the U.S and in Mexico, as well as for 
non-Hispanic men across the U.S.. However, the next two cancer sites, liver and stomach, 
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had higher rankings in fathers of our participants than in any other population of in the U.S., 
and again resembled the ranking in Mexico.
Comparison with local cancer registry data
Comparing our rankings with age-adjusted incidence of clinically-diagnosed cancers from 
the Cameron County Cancer Registry (2005-2009) confirms our key observations, 
particularly the higher frequency of gastrointestinal system cancers than in other 
populations.(28) Table 5 shows strikingly higher incidence in Cameron County of liver and 
stomach cancer among Hispanic men compared with non-Hispanic men, but lower age-
adjusted incidence of the more common cancers such as the lung, bronchus and colon. In 
both men and women pancreatic cancer incidence is higher in Hispanics.
Conclusions
We show that gastrointestinal cancers, particularly liver cancer, are more frequent in the 
Mexican American population than other ethnic groups in the U.S. We also show that the 
elevated frequency of these cancers tracks with health-disparity risk factors: obesity, diabetes 
and metabolic syndrome. We also demonstrate that the diabetes epidemic may underlie 
increases in gastrointestinal cancers particularly in people under the age of 70 years. These 
data suggest that gastrointestinal system cancers will be important components in the 
growing pandemic of NCDs both in the U.S. and LMIC regions globally.(2)
Sixty percent of all cancers globally are in LMICs where there is often lack of access to 
cancer diagnosis and treatment; nearly a third of cases being in people under the age of 60 
years.(2) Similar conditions to those in LMICs are found on the US/Mexico border.(25) The 
predictions of a percentage increase in cancer incidence of 58% in LMICs by 2030 
compares with 40% in high income countries.(1) Liver cancer is among the most deadly 
cancers with a world incidence for 2012 of 15.3/100,000, but mortality of 14/100,000.(2) 
Among Hispanics it has half the five-year cancer-specific survival rate of non-Hispanic 
whites in both sexes, accounting for 11% of cancer deaths in Hispanics nationally. This is 
possibly due to late diagnosis and inadequate access to health care, but also to obesity.(3,13)
The community we study is in the poorest county in the U.S. However, the local cancer 
registry reports incidence and distinguishes ethnicity, at least for those with health insurance, 
but we are informed that only hospitals report to this registry (personal communication B. 
Smith). Seventy percent of the cohort have no insurance, and will not reach these hospitals. 
However, since the size and observation period of the cohort were too small to obtain 
accurate incidence data, we accessed registry data to validate our ranking of cancer sites. 
The high incidence of liver cancer in Hispanics in the registry (third most common among 
men, and sixth among women in our study) was striking. This contrasts with national data 
where liver cancer ranks below 13th.(31) For men this local ranking is considerably higher 
than among Hispanic and non-Hispanic males nationally and for women nationally liver 
cancer is not even among the top 10 most common cancers. We have already reported high 
rates of elevated alanine transaminase and genetic factors for liver disease in our population 
as well as high frequency of end-stage liver disease, and more recently, high rates of fatty 
liver on ultrasound.(32-36) Alcohol abuse is not highly prevalent and hepatitis virus 
Garza et al. Page 6













infections are not common.(34) Together these observations suggest there may be high 
frequency of non-alcoholic fatty liver disease. Indeed, local physicians report seeing large 
numbers of patients with nonalcoholic steatohepatitis (NASH) which is likely a driver of 
liver cancer in this population.
The greater odds of having any cancer in participants with diabetes, particularly in those 
under the age of 70 years, suggests that diabetes mostly impacts occurrence o early cancers. 
Furthermore a participant with the metabolic syndrome had a higher likelihood of reporting 
a family history of cancer suggesting that the components of the metabolic syndrome, 
particularly obesity and diabetes, contribute to clustering of cancers in the immediate family. 
(37,38)
A strength of our approach is the use of data from relatives of the CCHC participants which 
increased the sample size by as much as 10-fold and expanded the timeline over many years. 
Nevertheless, there are considerable limitations to our study. Use of nested data from our 
cohort does not account for the possibility that not all the relatives are members of the target 
community and the timeframe is unclear. Furthermore, the reliability of the reports of 
cancer, particularly common metastatic sites, cannot be confirmed. The numbers of cohort 
participants themselves with cancer were too small to analyze for individual cancer sites, 
and we do not have actual mortality data or independent cancer diagnosis even for the 
participants. Data from relatives were limited and did not include age at cancer onset or at 
death, and could not be validated with pathological diagnoses. Among relatives the data 
from parents were the most complete and we have a reliable denominator. Consequently we 
used only data from parents in most of our analyses among relatives. Regardless of these 
important limitations, this approach using participant-reported data produces the only 
comprehensive information we have on cancer in this community. To generate accurate data 
prospectively would require considerable expenditure of time and money to obtain a 
sufficiently large sample size, number of end points and longer follow-up period for 
statistical power. However, the self-reported approach we used has been validated in one 
study by correlating up to 84% of self-reported cancers with pathology from medical 
records.(39) Given these limitations and to validate our data further, we used local registry 
data to confirm the relative importance of gastrointestinal cancers in local Hispanic patients.
(table 5) Local registry data, however, also suffers from limitations since the most consistent 
reporting is from local hospitals and uninsured patients such as those in our cohort receive 
hospital care from other centers in Texas funded to take them, or in Mexico, from where we 
have no data.(11,24) How the registry data may be skewed by winter visitors (Winter 
Texans) is illustrated by the high ranking of melanoma in Texas cancer registry data (13.7% 
overall, but only 3.8% in Hispanics).(28) Finally, we could not compare our data directly 
with registry data because we were unable to estimate age-adjusted incidence. Despite these 
limitations the prominence of gastrointestinal cancers is consistent and striking.
The Mexican-American population on the U.S./Mexico border has limited access to health 
care and preventive practices such as screening for cancer.(40) Obesity and diabetes rates in 
this community are among the highest reported in the nation. These data show the 
importance of gastrointestinal cancers, particularly liver cancer, in such disadvantaged 
populations. Both nationally and globally the only practical approach is prevention. These 
Garza et al. Page 7













data are therefore useful for planning cancer prevention programs. Cohorts such as ours also 
provide a useful testing ground for low cost, low-tech screening, and use of new biomarkers 
to detect early disease. Finally, the high prevalence of obesity in this population is most 
likely due to lifestyle behaviors such as inadequate physical activity and poor eating habits 
which also highlights the need for obesity prevention and behavioral change interventions.
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Fig. 1. Algorithm showing the numbers of participants and their relatives on whom we had 
cancer data, and the number and frequencies of all cause cancers in the groups
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Table 1
Bivariate analysis of weighted demographic and biological variables for reported cancer 
in participants, Cameron County Hispanic Cohort, 2000–2011
Total (n=2547) With Cancer (n=71) Odds Ratio for cancer (95% CI)
Age (years) n* n (%)* OR (95%CI)*
 Less than 45 1282 12 (9.3) 0.07 (0.02, 1.20)
 45 – 54 525 21 (21.0) 0.48 (0.19, 1.22)
 55 – 64 470 15 (16.7) 0.40 (0.11, 1.51)
 65 and older 277 23 (53.0) reference
 Age (continuous) (mean/SD) 45.2 (15.5) 1.06 (1.04, 1.08)
Gender
 Male 862 25 (56.7) 1.55 (0.67, 3.56)
 Female 1692 46 (43.4) reference
Employment status
 Employed 1251 24 (44.8) 0.88 (0.34, 2.13)
 Unemployed 1303 47 (55.2) reference
Poverty (2014 guidelines)
 Below the poverty 1688 43 (45.4) 0.26 (0.11, 0.64)
 Above the poverty 296 16 (54.6) reference
Country of Birth
 Mexico 1648 37 (46.7) reference
 United States 866 32 (53.3) 1.78 (0.77, 4.14)
Medical Status
 Diabetes (ADA 2010 definition) 728 29 (66.8) 2.62 (1.19, 5.79)
 Insulin Resistance (HOMA>3.15) 910 23 (47.6) 0.92 (0.45, 1.90)
Body Mass Index
 BMI<25 419 10 (16.9) reference
 25≤BMI<30 819 25 (33.0) 0.91 (0.23, 3.65)
 30≤BMI<35 741 18 (25.9) 0.82 (0.18, 3.87)
 35≤BMI<40 337 11 (21.1) 1.60 (0.31, 8.17)
 BMI ≥ 40 223 6 (3.1) 0.31 (0.06, 1.49)
Obese
 Yes 1297 35 (49.6) 0.96 (0.40, 2.32)
 No 1245 36 (50.4) reference
Metabolic Syndrome
 Yes 1172 39 (59.2) 1.52 (0.61, 3.75)
 No 1204 30 (40.7) reference
Smoking Status
 Never 1390 32 (19.0) reference
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Total (n=2547) With Cancer (n=71) Odds Ratio for cancer (95% CI)
 Former 758 31 (65.5) 2.09 (1.01, 4.30)
 Current 406 8 (15.5) 1.43 (0.34, 5.71)
Family history of cancer
 Any relative 968 34 (40.7) 1.09 (0.47, 2.53)
 Father 304 14 (17.8) 1.67 (0.48, 5.84)
 Mother 316 6 (5.9) 0.44 (0.16, 1.25)
 At least one sibling 249 14 (25.4) 1.31 (0.46, 3.69)
 Other male relative 226 7 (11.1) 0.55 (0.17, 1.75)
 Other female relative 328 12 (16.0) 0.61 (0.22, 1.73)
*
Unweighted frequency, weighted percentages and OR (95%CI)
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Table 2
Participant-reported family history of cancer of the participants and association with 
selected risk factors for cancer among the participants themselves (n=2,547)
Family history of cancer
Characteristics of the CCHC participant
Diabetes Obesity Insulin Resistance Metabolic Syndrome (41)
OR* (95% C.I.) OR* (95% C.I.) OR* (95% C.I.) OR* (95% C.I.)
At least 1 parent 1.14 (0.79, 1.64) 1.13 (0.82, 1.56) 1.09 (0.78, 1.51) 1.73 (1.26, 2.37)
Father 0.94 (0.58, 1.51) 1.19 (0.77, 1.83) 1.44 (0.97, 2.13) 1.36 (0.90, 2.06)
Mother 1.34 (0.87, 2.05) 1.11 (0.74, 1.66) 0.86 (0.57, 1.31) 1.89 (1.28, 2.77)
Both parents 1.13 (0.47, 2.68) 1.55 (0.68, 3.54) 1.30 (0.52 – 3.28) 1.17 (0.53, 2.62)
At least 1 sibling 1.17 (0.46, 2.97) 1.78 (0.68, 4.61) 0.74 (0.28, 1.93) 1.29 (0.46, 3.61)
2 or more siblings 0.64 (0.19, 2.17) 2.68 (0.81, 8.93) 0.80 (0.22, 2.97) 3.40 (1.06, 10.91)
Any relative* 1.14 (0.83, 1.55) 1.22 (0.92, 1.62) 1.01 (0.76, 1.34) 1.45 (1.12, 1.88)
*
Weighted Odds Ratio and 95% Confidence Interval
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